Supernus Pharmaceuticals develops and sells medications for treating central nervous system diseases. Its commercial products include Trokendi XR for epilepsy and migraine headaches, Oxtellar XR for epilepsy seizures, Qelbree for ADHD, MYOBLOC for cervical dystonia, and more. They also have various product candidates in clinical trials and preclinical stages for treating CNS.